Clinical Trial Update: CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a) [Phase 3]

View source ↗

Summary

Phase 3 trial in previously untreated chronic lymphocytic leukemia evaluating obinutuzumab with chlorambucil completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01